Article info
PostScript
Correspondence
Phosphodiesterase-5 inhibitors as novel cardioprotective agents: have we reached threshold for large-scale clinical trials?
- Correspondence to Dr. David Charles Hutchings, Institute of Cardiovascular Sciences, University of Manchester, 46 Grafton Street, Manchester M139NT, UK; hutchingsdc{at}googlemail.com
Citation
Phosphodiesterase-5 inhibitors as novel cardioprotective agents: have we reached threshold for large-scale clinical trials?
Publication history
- First published October 12, 2017.
Online issue publication
October 12, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.